MobiHealth News October 10, 2022
Dr. Oliver Bleck, area head of Europe South at Roche, describes the pharma giant’s work in personalized medicine.
Roche, one of the largest pharma companies in Europe, has been expanding its ambitions in genomic and personalized medicine, emerging practices that use information about a patient’s genetic profile or proteins to prevent, diagnose or treat disease.
Dr. Oliver Bleck, area head of Europe South at Roche, joined MobiHealthNews to discuss Roche’s advancements in oncology, its current work in genomics, and what Roche hopes to contribute regarding personalized medicine as time progresses.
MobiHealthNews: You’ve had a long career at Roche. How have you seen oncology treatment advance over the past 20 years, especially when it comes to digital healthcare?
Oliver...
Today's Sponsors
Today's Sponsor